New Drug Shows Promise for Hard-to-Treat Ovarian Cancer
Researchers tested a new targeted cancer drug called mirvetuximab soravtansine (MIRV) on patients with ovarian cancer that had stopped responding to standard …
Read Moremirvetuximab soravtansine
All content tagged with "mirvetuximab soravtansine"
New Test Helps Find Best Treatment for Hard-to-Treat Ovarian Cancer
Researchers in Poland tested ovarian cancer tumors to see which patients might benefit from a newer type of cancer treatment called mirvetuximab soravtansine. …
Read More